2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Ezra A. Amsterdam, Nanette K. Wenger, Ralph G. Brindis, Donald E. Casey, Théodore G. Ganiats, David R. Holmes, Allan S. Jaffe, Hani Jneid, Rosemary F. Kelly, Michael C. Kontos, Glenn N. Levine, Philip R. Liebson, Debabrata Mukherjee, Eric D. Peterson, Marc S. Sabatine, Richard W. Smalling, Susan J. Zieman

Journal of the American College of Cardiology

September 23, 2014

10.1016/j.jacc.2014.09.017

Cited by 3,582

Abstract

Related Papers

Clinical Practice Guidelines We Can Trust

Board on Health Care Services|National Academies Press eBooks|2011|3.1k

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

H. J. Dargie|The Lancet|2001|1.8k

Finding What Works in Health Care: Standards for Systematic Reviews

Jill Eden, Laura A. Levit, Alfred O. Berg et al.|Unknown|2013|957

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

Sidney C. Smith, Emelia J. Benjamin, Robert O. Bonow et al.|Journal of the American College of Cardiology|2011|913

Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial

The OASIS-6 Trial Group*|JAMA|2006|906